glp 1 physiology informs the pharmacotherapy of obesity pharmacotherapy: incretin action in central nervous system: Trends in Pharmacological Sciences Glucagon-Like Peptide-1 Based Therapies: A

The ratio between serum levels of insulin-like growth factor (IGF)-1 and the IGF binding proteins (IGFBP)-1, 2 and 3 decreases with age in healthy adults and is increased in acromegalic patients

These studies should incorporate sensitive biomarkers, including neuroimaging (MRI-based volumetry and functional connectivity), cerebrospinal fluid A/tau ratios, and emerging blood-based markers of oxidative stress and inflammation

GLP-1 receptor agonists carry a boxed warning regarding thyroid C-cell tumors, based on rodent studies showing increased incidence of medullary thyroid carcinoma (MTC) at high doses

However, there were changes observed in claudin-5